Key statistics
On Friday, Resmed Inc (RME:STU) closed at 219.70, -9.14% below its 52-week high of 241.80, set on Jan 30, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 219.70 |
---|---|
High | 219.70 |
Low | 219.70 |
Bid | 214.80 |
Offer | 217.80 |
Previous close | 212.60 |
Average volume | 0.00 |
---|---|
Shares outstanding | 146.63m |
Free float | 145.66m |
P/E (TTM) | 28.56 |
Market cap | 37.30bn USD |
EPS (TTM) | 8.91 USD |
Annual div (ADY) | 1.89 EUR |
---|---|
Annual div yield (ADY) | 0.86% |
Div ex-date | May 08 2025 |
Div pay-date | Jun 12 2025 |
Data delayed at least 15 minutes, as of Jul 11 2025.
More ▼
Announcements
- Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025
- Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025
- Resmed Acquires VirtuOx
- Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025
- Resmed Names Salli Schwartz as Chief Investor Relations Officer
- Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US
- Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025
- New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer
- Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
- ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep
More ▼